Condition: Epstein-Barr Virus-associated Lymphoproliferative Diseases · Chronic Active Epstein-Barr Virus Infection · EBV Associated Lymphoma · Sponsor: Fudan University
This clinical trial is designed as a single-arm, two-center, open-label, prospective study. All participants are enrolled in the standard-dose unrelated umbilical cord blood transplantation group to evaluate the efficacy and safety of unrelated umbilical cord blood transplantation in treating Epstein-Barr virus-associated lymphoproliferative disease.
This description comes directly from the study's public registry record.
Jiexian Ma · +86 13764520566 · jiexianma@hotmail.com
Always discuss trial participation with your own doctor first.
| Huadong hospital, Fudan university | Shanghai, Shanghai Municipality, China | Recruiting |
| Huashan Hospital, Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07381738